Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Fiala, Mark A  [Clear All Filters]
2015
Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM. Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma. Leuk Lymphoma. 2015:1-29.
2016
Fiala MA, Slade M, Wang S, Park S, DiPersio J, Stockerl-Goldstein K. The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation. Leuk Lymphoma. 2016:1-3.
Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, et al. Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation. Leuk Res. 2016;49:1-6.
2018
Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Dávila J, Vij R, Fiala MA, Gozzetti A, Grzasko N, Milunovic V, et al. Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma. 2018:1-6.
2021
Xiang J, Shi M, Fiala MA, Gao F, Rettig MP, Uy GL, Schroeder MA, Weilbaecher KN, Stockerl-Goldstein K, Mollah S, et al. Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors. Blood Adv. 2021.
2023
Slade M, Fiala MA, Kirchmeyer M, King J, Gao F, Schroeder MA, A Stewart K, Stockerl-Goldstein K, Chen C, Vij R. Continuous Elotuzumab, Pomalidomide and Dexamethasone Maintenance Following Second Autologous Transplant for Multiple Myeloma: Results of a Prospective, Phase 2 Multicenter Trial. Transplant Cell Ther. 2023.